GRAIL Inc.
GRAL
Kedudukan dalam Saham
#3035
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Harga Saham
$132.85
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$5.93B
Perubahan (1 hari)
6.56%
Perubahan (1 tahun)
66.56%
Negara
US
Perdagangan GRAIL Inc. (GRAL)
Kategori
Healthcare
EPS untuk GRAIL Inc. (GRAL)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham GRAIL Inc., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk GRAIL Inc. dari 2018 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2025 | $-11.11 | -82.51% |
| 2024 | $-63.54 | 34.62% |
| 2023 | $-47.20 | -72.85% |
| 2022 | $-173.87 | 332.73% |
| 2021 | $-40.18 | 1,494.44% |
| 2020 | $-2.52 | 26.63% |
| 2019 | $-1.99 | -17.77% |
| 2018 | $-2.42 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| $27.74 | - |
NL
|
|
| - | - |
CH
|
